Pharmaceutical Anti-counterfeiting
Technologies: Market Analysis
2014-2024

©notice
This material is copyright by visionga...
Contents
1. Executive Summary
1.1 Market Highlights
1.2 Overview of the Report Content
1.3 Research and Analysis Methods
1...
Contents
2.6.4 The Impact of Pharmaceutical Counterfeiting on Governments
2.6.5 The Impact of Counterfeiting on the Global...
Contents
4. Leading Companies in the Pharmaceutical Anti-counterfeiting
Technologies Market
4.1 3M: A Diversified Technolo...
Contents
4.13.2 NanoGuardian’s Global Licensing Agreement with Capsugel
4.13.3 The Closed-Loop Protection System
4.13.4 Ma...
Contents
6. Leading National Markets 2014-2024
6.1 Pharmaceutical Counterfeiting: A Global Conundrum
6.1.1 How Will Nation...
Contents
7.2.2.1 Anti-counterfeiting and Product Protection Programme (A-CAPPP)
7.2.2.2 Anti-counterfeiting Group (ACG)
7....
Contents
7.6 STEP Analysis of the Pharmaceutical Anti-counterfeiting Technologies Market, 2014-2024
7.6.1 Social Factors
7...
Contents
8.1.1 Current State of Counterfeiting in the Pharmaceutical Industry
8.1.2 AlpVison’s Key Technologies and Strate...
Contents
List of Tables
Table 2.1 Global Reported Incidents of Drug Counterfeiting, 2008-2012
Table 2.2 Classification of ...
Contents
($m, AGR%, CAGR%) by Sector, 2017-2024
Table 5.4 The Global Pharmaceutical Anti-counterfeiting Technologies Marke...
Contents
2024
Table 7.2 Selected Instances of Counterfeiting Activities, 2012-2013
Table 7.3 Selected Instances of Counter...
Contents
List of Figures
Figure 2.1 Global Reported Incidents of Drug Counterfeiting, 2008-2012
Figure 2.2 Flow Chart of t...
Contents
by Sector, 2024
Figure 5.8 RFID: Revenue Forecast ($m), 2012-2024
Figure 5.9 Security Printing: Revenue Forecast ...
Contents
Organisations Mentioned in this Report
3M
Adhesives Research
Ahura Scientific
Alien Technologies
AlpVision
Altegr...
Contents
Chesapeake
Colorcon
Cortegra
Covectra
Digital China
Directorate General of Foreign Trade [India]
Domino
Drugs Sta...
Contents
International Anti-Counterfeiting Coalition (IACC)
International Federation of Pharmaceutical Manufacturers & Ass...
Contents
Organisation for Economic Co-operation and Development (OECD)
Pacific Holographics
Paralec Inc
Partner for Safe M...
Contents
ThermoFisher Scientific
TruTag Technologies
United Nations
University of South Dakota
UPM
UPM Kymmene
UPM Raflata...
Pharmaceutical Anti-counterfeiting Technologies:
Market Analysis 2014-2024
Passive RFID tags operate without a separate ex...
Pharmaceutical Anti-counterfeiting Technologies:
Market Analysis 2014-2024
Table 4.16 Zebra Technologies: Product Groups a...
Pharmaceutical Anti-counterfeiting Technologies:
Market Analysis 2014-2024
Table 5.9 Holograms/OVD: Revenue Forecast ($m, ...
Pharmaceutical Anti-counterfeiting Technologies:
Market Analysis 2014-2024
8. Expert Opinions
8.1 Interview with Dr Fred J...
Upcoming SlideShare
Loading in...5
×

Pharmaceutical Anti Counterfeiting Technologies 2014-2024

1,841

Published on

For an Executive Summary of this report please contact ediz.ibrahim@visiongain.com (+44 (0)20 7549 9976) or refer to our website http://www.visiongain.com/Report/1154/Pharmaceutical-Anti-counterfeiting-Technologies-Market-Analysis-2014-2024

Published in: Business, News & Politics
0 Comments
2 Likes
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
1,841
On Slideshare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
92
Comments
0
Likes
2
Embeds 0
No embeds

No notes for slide

Pharmaceutical Anti Counterfeiting Technologies 2014-2024

  1. 1. Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2014-2024 ©notice This material is copyright by visiongain. It is against the law to reproduce any of this material without the prior written agreement of visiongain. You cannot photocopy, fax, download to database or duplicate in any other way any of the material contained in this report. Each purchase and single copy is for personal use only.
  2. 2. Contents 1. Executive Summary 1.1 Market Highlights 1.2 Overview of the Report Content 1.3 Research and Analysis Methods 1.4 Glossary of Terms Related to Pharmaceutical Anti-counterfeiting Technologies 2. Introduction to Pharmaceutical Counterfeiting 2.1 Drug Counterfeiting: A Thorn in the Side of the Pharma Industry 2.1.1 Regional Differences Hindering Information Exchange 2.1.2 Rising Counterfeiting Incidents in Developed Regions 2.2 The Most Commonly Counterfeited Drugs 2.3 Types of Counterfeit Drugs 2.3.1 Substandard Pharmaceutical Products as Counterfeits 2.3.2 Global Outsourcing of Active Pharmaceutical Ingredients (APIs) 2.3.2.1 Heparin Contamination 2.3.2.2 Stricter Enforcement needed for API Control 2.4 Why are Drugs Counterfeited? 2.4.1 Methods of Producing Pharmaceutical Counterfeits 2.4.2 Moving Counterfeits into the Pharmaceutical Supply Chain 2.4.3 Corruption Within the Pharmaceutical Distribution System 2.5 The Internet and its Role in Pharmaceutical Counterfeiting 2.5.1 Online Pharmacies: A Cheap Distribution System for Pharma Counterfeits 2.5.2 Legal Online Pharmacies: A Convenient and Quick Way of Dispensing Medication 2.5.3 Verifying the Authenticity of Online Pharmacies 2.6 Pharmaceutical Counterfeiting: The Global Costs 2.6.1 The Impact of Pharmaceutical Counterfeiting on Consumers 2.6.2 The Impact of Counterfeiting on Healthcare Providers 2.6.3 The Impact of Counterfeiting on Pharma Manufacturers www.visiongain.com
  3. 3. Contents 2.6.4 The Impact of Pharmaceutical Counterfeiting on Governments 2.6.5 The Impact of Counterfeiting on the Global Pharmaceutical Industry 2.6.5.1 Operation Pangea: Europol’s Fight Against Counterfeiting 2.6.5.2 Legislative Deficiencies Aiding Counterfeiting Operations 2.7 Factors Fuelling Pharmaceutical Counterfeiting 2.7.1 An Erratic Supply or Shortage of Drugs Promotes Counterfeiting 2.7.2 Price Differentials and High Price Medicines Drive People to Cheaper Counterfeit Alternatives 2.7.3 Drug Misuse Creates a Market for Counterfeiting 2.7.4 Trade through Free-Trade Zones/Free Ports Is an Important Route for Counterfeiters 2.7.5 The Trade of Pharmaceuticals through Several Intermediaries Helps Hide Counterfeit Drugs 2.7.6 Counterfeiters Target Developed Markets 2.7.7 Parallel Trade – a Counterfeiting Route in Europe 3. Leading Technologies and Applications 3.1 Passive Technologies 3.1.1 Security Inks as Anti-counterfeiting Technologies 3.1.2 Holograms as Anti-counterfeiting Technologies 3.1.3 Visual Inspection as the First Line of Defence Against Drug Counterfeiting 3.1.4 Overt and Hidden Imaging 3.2 Active Technologies 3.2.1 Electromagnetic Tags – Radio Frequency Identification (RFID) as Anti-counterfeiting Technologies 3.2.2 Taggants as Anti-counterfeiting Technologies 3.2.3 Mass Encoding Technology 3.2.3.1 Digital Mass Serialisation Technology (DMS) 3.2.3.2 Digital Mass Encryption (DME) 3.2.3.3 Barcode Applications: Serialisation is Key www.visiongain.com
  4. 4. Contents 4. Leading Companies in the Pharmaceutical Anti-counterfeiting Technologies Market 4.1 3M: A Diversified Technology Multinational 4.2 Alien Technology: RFID Technology Specialist 4.3 AlpVision: Cryptoglyph Security Solution 4.3.1 Fingerprint: A ‘Read Only’ Technology 4.3.2 Krypsos Platform 4.3.3 Cryptoglyph 4.3.4 AlpVision: Integration of Phone Applications Important for Future Growth 4.4 Angstrom Technologies – Security Inks 4.5 Authentix: Product Authentication and Brand Protection 4.5.1 Product-specific Track-and-Trace Solutions 4.5.2 Packaging Solutions 4.6 Avery Dennison: RFID Technologies Expert 4.7 Colorcon 4.7.1 Colorcon’s Taggants: On-Dose ID 4.7.2 Colorcon’s Brand Enhancement Service 4.8 Chesapeake: Acquired by The Caryle Group 4.9 Covectra 4.9.1 Covectra’s Authenti-Track System for Product Tracing 4.9.2 Covectra’s ControlTrack System for Combating Opioid Drug Diversion 4.10 Everest Holovisions 4.11 InkSure Technologies: Leader in Cloud-based Authentication 4.12 Intermec: A Workflow Performance Company 4.12.1 Automatic Information Data Capture 4.12.2 Will Recent Acquisitions Spell an Uncertain Future? 4.13 NanoGuardian 4.13.1 NanoCodes: Data Carriers of Limitless Potential www.visiongain.com
  5. 5. Contents 4.13.2 NanoGuardian’s Global Licensing Agreement with Capsugel 4.13.3 The Closed-Loop Protection System 4.13.4 Major Players Showing Interest In NanoGuardian’s Technologies 4.14 ThermoFisher Scientific 4.14.1 Acquisition of Ahura Scientific 4.14.2 Continous Growth and Expansion into Emerging Markets 4.14.3 ThermoFisher Scientific’s TruScan Technology 4.15 TruTag Technologies 4.15.1 TruTag’s Silica Microtag Technology 4.16 UPM Raflatac 4.17 Zebra Technologies 5. Global Pharmaceutical Anti-counterfeiting Technologies Market 2014-2024 5.1 Pharmaceutical Anti-counterfeiting Technologies: Market Overview 5.1.1 Size of the Pharmaceutical Anti-counterfeiting Technologies Market in 2012 and 2013 5.1.2 Global Pharmaceutical Anti-counterfeiting Technologies Market: Growth Trends 5.1.3 Global Pharmaceutical Anti-counterfeiting Technologies Market Forecast 2012-2017 5.1.4 Global Pharmaceutical Anti-counterfeiting Technologies Market Forecast 2017-2024 5.1.5 Changing Market Shares by Sector, 2012-2024 5.2 Pharmaceutical RFID Market Forecast 2012-2024 5.3 Pharmaceutical Security Printing Market Forecast 2012-2024 5.4 Pharmaceutical Taggants Market Forecast 2012-2024 5.5 Pharmaceutical Hologram/OVD Market Forecast 2012-2024 5.6 Other Pharmaceutical Anti-counterfeiting Technologies Market Forecast 2012-2024 www.visiongain.com
  6. 6. Contents 6. Leading National Markets 2014-2024 6.1 Pharmaceutical Counterfeiting: A Global Conundrum 6.1.1 How Will National Market Shares Change to 2024? 6.2 Regional Pharmaceutical Anti-counterfeiting Market Forecast, 2014-2024 6.2.1 The US Market 6.2.2 EU5: Europe’s Leading Anti-counterfeiting Technology Markets 6.2.3 Japan: Uptake of Key Technologies Important for Market Growth 6.2.4 China: Set to See High Growth Rates Continue Until 2017 6.2.5 India: New Mandates will Help Deter Counterfeiters 6.2.5.1 Collaboration with the WHO will Help Regain Consumer Confidence in Pharma Products 6.2.6 Brazil: South America’s Largest Pharmaceutical Market 6.2.7 Russia: Highest Per-Capita Spending on Healthcare of All the BRIC Nations 7. Issues Affecting the Pharmaceutical Anti-counterfeiting Technologies Market 7.1 SWOT Analysis of the Pharmaceutical Anti-counterfeiting Technologies Market, 2014-2024 7.2 Strengths 7.2.1 Growing Interest from Pharmaceutical Companies in Tackling Counterfeiting 7.2.1.1 AstraZeneca 7.2.1.2 GlaxoSmithKline 7.2.1.3 Johnson & Johnson 7.2.1.4 Novartis 7.2.1.5 Pfizer 7.2.1.6 Sanofi 7.2.2 Organisations Promoting the Awareness and Implementation of Anti-Counterfeiting Solutions www.visiongain.com
  7. 7. Contents 7.2.2.1 Anti-counterfeiting and Product Protection Programme (A-CAPPP) 7.2.2.2 Anti-counterfeiting Group (ACG) 7.2.2.3 Brazil’s National Health Surveillance Agency (ANVISA) 7.2.2.4 Canadian Anti-counterfeiting Network (CACN) 7.2.2.5 Center for Healthcare Supply Chain Research 7.2.2.6 European Alliance for Access to Safe Medicines (EAASM) 7.2.2.7 European Federation of Pharmaceutical Industries and Associations (EFPIA) 7.2.2.8 International Anti-counterfeiting Coalition (IACC) 7.2.2.9 International Authentication Association (IAA) 7.2.2.10 The Pharmaceutical Security Institute (PSI) 7.2.3 Track-and-Trace Solutions Boosting Supply Chain Efficiency 7.2.4 New Technologies Providing More Comprehesive Anti-Counterfeiting Protection 7.2.5 Litigation Proceedings over Counterfeit Products Affecting Profitability 7.3 Weaknesses 7.3.1 The Lack of Standardisation Across the Industry as a Whole Will Impede Technology Adoption 7.3.2. Insufficient Quantitative Measurement of the Effectiveness of Anti-counterfeiting Technologies 7.3.2.1 Complexity of Factors Influencing Drug Revenue Makes Quantifying Commercial Impact of Anti-counterfeiting Technologies Difficult 7.3.3 Technology Reliability and the Ease of Integration into Manufacturing Processes 7.3.4 Lack of Cooperation Between Various Governmental Organisations Aids Drug Counterfeiters 7.4 Opportunities 7.4.1 Constantly Evolving Technologies Allows for Product Innovation 7.4.2 Anti-counterfeiting Technologies for the Prevention of Online Fraud 7.5 Threats 7.5.1 The High Volume of Counterfeiting Activities Could Devalue Anti-counterfeiting Solutions 7.5.2 Developing Countries Lack Infrastructure to Effectively Deal with Counterfeiting 7.5.3 Pace of Innovation May Not Keep up with the Counterfeiters www.visiongain.com
  8. 8. Contents 7.6 STEP Analysis of the Pharmaceutical Anti-counterfeiting Technologies Market, 2014-2024 7.6.1 Social Factors 7.6.1.1 The Weak Enforcement of Legislation 7.6.1.2 Corruption: A Hindrance to Eradicating Pharmaceutical Counterfeiting 7.6.1.3 Changing Public Perception and Consumer Education 7.6.1.4 Concerns Over Information Privacy 7.6.2 Technological Factors 7.6.2.1 Smartphone Read and Verify: A Customer Empowerment Tool 7.6.2.2 US FDA’s Counterfeit Detection Device 7.6.2.3 UV and IR Inks Being Used Covertly for Increased Security 7.6.2.4 Bokode: A Potential Replacement for Barcodes? 7.6.2.5 SigNature DNA 7.6.3 Economic Factors 7.6.3.1 Implementation Costs of Anti-counterfeiting Technologies 7.6.3.2 Anti-counterfeiting Technologies Require R&D Investment 7.6.4 Political Factors 7.6.4.1 World Health Organization: The IMPACT Programme 7.6.4.2 Anti-Counterfeiting Trade Agreement (ACTA) 7.6.4.3 The Fagan Civil Case: Effects of Litigation on Players in the Drug Supply Chain 7.6.4.4 Legislations for Supply Chain Security 7.6.4.5 E-pedigree: A Catalyst for Product Serialisation 7.6.4.5.1 E-pedigree: Challenges Involved in Implementation 7.6.4.5.2 EU and the US: Differing Supply Chain Authentication 7.6.4.6 UK MHRA: Falsified Medical Products Strategy 7.6.4.7 The EU’s Falsified Medicines Directive 8. Expert Opinions 8.1 Interview with Dr Fred Jordan, Chief Executive Officer, AlpVision www.visiongain.com
  9. 9. Contents 8.1.1 Current State of Counterfeiting in the Pharmaceutical Industry 8.1.2 AlpVison’s Key Technologies and Strategies for Combating Counterfeiters 8.1.3 The Future of Anti-counterfeiting Technologies 8.1.4 On Whom do the Responsibilities for Counterfeiting Prevention Lie? 8.1.5 The Major Barriers Facing Implementation of Anti-counterfeiting Technologies 8.1.6 Future Growth Drivers of the Anti-counterfeiting Technologies Market 8.2 Interview with a Spokesperson from a Leading Anti-counterfeiting Technologies Company Based in the US. 8.2.1 On the Threats Posed by Counterfeit Products 8.2.2 Keeping Up with the Counterfeiters: An Impossible Task? 8.2.3 Duty of Care 8.2.4 DNA Technology: The Innovation Needed to Defeat Counterfeiting? 8.2.5 Future Prospects of the Pharma Anti-counterfeiting Industry 9. Conclusion 9.1 The Pharmaceutical Anti-counterfeiting Technologies Industry 2014-2024 9.2 Government Mandates Will Fuel Growth in the Market 9.3 The US Will Continue to Dominate the Market 9.4 New Directives Will Ensure Track-and-Trace Market Leadership 9.5 European Preference for Mandated 2D Barcode Technology 9.6 Improved Regulation of Online Pharmacies Necessary for Anti-counterfeiting Technologies to be Effective 9.7 Market Expansion Will be Dependent on the Development of Industry-Wide Standards for the Use of the Available Technologies www.visiongain.com
  10. 10. Contents List of Tables Table 2.1 Global Reported Incidents of Drug Counterfeiting, 2008-2012 Table 2.2 Classification of Counterfeit Pharmaceutical Products Table 3.1 Anti-counterfeiting Technologies Used in the Pharmaceutical Industry Table 3.2 Leading Anti-counterfeiting Security Ink Manufacturers, 2013 Table 3.3 Leading Anti-counterfeiting Holographic Labelling Manufacturers, 2013 Table 3.4 Leading Radio Frequency Identification (RFID) System Manufacturers, 2013 Table 3.5 Leading Pharmaceutical Taggants Manufacturers, 2013 Table 4.1 3M: Revenue ($m) and Revenue Shares (%) by Business Segment, 2012 Table 4.2 Alien Technologies: Types of RFID Readers Produced, 2013 Table 4.3 AlpVision: Products and Applications, 2013 Table 4.4 Angstrom Technologies: Products and Applications, 2013 Table 4.5 Avery Dennison: Revenue ($m) and Revenue Shares (%) by Business Segment, 2012 Table 4.6 Avery Dennison: RFID Products for Use in Pharmaceuticals, 2013 Table 4.7 Colorcon: Product Groups, Sub-groups, and Examples 2013 Table 4.8 Everest Holovision: Products and Applications, 2013 Table 4.9 InkSure Technologies: Products and Applications, 2013 Table 4.10 InkSure Technologies: Historical Revenue ($m, AGR %) 2009-2012 Table 4.11 Intermec: Product Lines and Descriptions, 2013 Table 4.12 Intermec: Historical Revenue ($m, AGR %) 2009-2012 Table 4.13 ThermoFisher Scientific: Historical Revenue ($bn) 2009-2012 Table 4.14 ThermoFisher Scientific: Revenue Shares (%) by Region, 2012 Table 4.15 UPM Raflatac: Product Groups and Descriptions, 2013 Table 4.16 Zebra Technologies: Product Groups and Descriptions, 2013 Table 4.17 Zebra Technologies: Historical Revenue ($m, AGR%) 2009-2012 Table 5.1 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) and Market Shares (%) by Sector, 2012 Table 5.2 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Revenue Forecast ($m, AGR%, CAGR%) by Sector, 2012-2017 Table 5.3 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Revenue Forecast www.visiongain.com
  11. 11. Contents ($m, AGR%, CAGR%) by Sector, 2017-2024 Table 5.4 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Revenue ($m) by Sector, 2012, 2017, 2024 Table 5.5 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Sector, 2012, 2017, 2024 Table 5.6 RFID: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024 Table 5.7 Security Printing: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024 Table 5.8 Pharmaceutical Taggants: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024 Table 5.9 Holograms/OVD: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024 Table 5.10 Other Technologies: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024 Table 6.1 The Global Pharmaceutical Anti-counterfeiting Technologies: Revenue Forecast ($m, AGR%, CAGR%) by Region, 2012-2017 Table 6.2 The Global Pharmaceutical Anti-counterfeiting Technologies: Revenue Forecast ($m, AGR%, CAGR%) by Region, 2017-2024 Table 6.3 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Region, 2012, 2017, 2024 Table 6.4 US Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024 Table 6.5 EU5 Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024 Table 6.6 Japanese Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024 Table 6.7 Chinese Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024 Table 6.8 Indian Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024 Table 6.9 Brazilian Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024 Table 6.10 Russian Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024 Table 7.1 SWOT Analysis of the Pharmaceutical Anti-counterfeiting Technologies Industry, 2014- www.visiongain.com
  12. 12. Contents 2024 Table 7.2 Selected Instances of Counterfeiting Activities, 2012-2013 Table 7.3 Selected Instances of Counterfeiting Activities, 2009-2011 Table 7.4 STEP Analysis for the Pharmaceutical Anti-counterfeiting Technologies Industry, 20142024 www.visiongain.com
  13. 13. Contents List of Figures Figure 2.1 Global Reported Incidents of Drug Counterfeiting, 2008-2012 Figure 2.2 Flow Chart of the Route Taken by Counterfeit Pharma Products Entering the Legal Supply Chain Figure 3.1 Holograms Anti-counterfeiting Technologies: Drivers and Restraints, 2014-2024 Figure 3.2 Basic Components of a RFID System Figure 3.3 RFID Anti-counterfeiting Technologies: Drivers and Restraints, 2014-2024 Figure 3.4 Taggants Anti-counterfeiting Technologies: Drivers and Restraints, 2014-2024 Figure 3.5 Barcode Anti-counterfeiting Technologies: Drivers and Restraints, 2014-2024 Figure 4.1 3M: Revenue Shares (%) by Business Segment, 2012 Figure 4.2 Authentix’s Global Monitoring Service: A Three Step Program Figure 4.3 Avery Dennison: Revenue Shares (%) by Business Segment, 2012 Figure 4.4 InkSure Technologies: Historical Revenue ($m) 2009-2012 Figure 4.5 Intermec: Historical Revenue ($m) 2009-2012 Figure 4.6 ThermoFisher Scientific: Historical Revenue ($bn) 2009-2012 Figure 4.7 ThermoFisher Scientific: Revenue Shares (%) by Region, 2012 Figure 4.8 Zebra Technologies: Historical Revenue ($m) 2009-2012 Figure 5.1 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Sector, 2012 Figure 5.2 The Global Pharmaceutical Anti-counterfeiting Technologies: Revenue Forecast ($m), 2012- 2017 Figure 5.3 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Revenue Forecast ($m), 2017-2024 Figure 5.4 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Revenue ($m) by Sector, 2012, 2017, 2024 Figure 5.5 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Sector, 2012 Figure 5.6 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Sector, 2017 Figure 5.7 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) www.visiongain.com
  14. 14. Contents by Sector, 2024 Figure 5.8 RFID: Revenue Forecast ($m), 2012-2024 Figure 5.9 Security Printing: Revenue Forecast ($m), 2012-2024 Figure 5.10 Pharmaceutical Taggants: Revenue Forecast ($m), 2012-2024 Figure 5.11 Holograms/OVD: Revenue Forecast ($m), 2012-2024 Figure 5.12 Other Technologies Revenue Forecast ($m), 2012-2024 Figure 6.1 US and EU5 Pharmaceutical Anti-counterfeiting Technologies: Revenue Forecast ($m), 2012-2024 Figure 6.2 China, India, Brazil and Russia Pharmaceutical Anti-counterfeiting Technologies Market: Revenue Forecast ($m), 2012-2024 Figure 6.3 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Region, 2012 Figure 6.4 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Region, 2017 Figure 6.5 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Region, 2024 Figure 6.6 US Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m), 2012-2024 Figure 6.7 EU5 Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m), 2012-2024 Figure 6.8 Japanese Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m), 20122024 Figure 6.9 Chinese Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m), 2012-2024 Figure 6.10 Indian Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m), 2012-2024 Figure 6.11 Brazilian Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m), 20122024 Figure 6.12 Russian Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m), 2012-2024 Figure 7.1 EU Supply Chain Authentication Strategy, 2013 Figure 7.2 US Supply Chain Authentication Strategy, 2013 Figure 9.1 Global Pharmaceutical Anti-counterfeiting Market: RFID, Security Printing, Holograms/OVD, and Taggants Revenue Forecast ($m), 2012-2024 www.visiongain.com
  15. 15. Contents Organisations Mentioned in this Report 3M Adhesives Research Ahura Scientific Alien Technologies AlpVision Altegrity Risk International American Academy of Pediatrics (AAP) American Express AmerisourceBergen Angstrom Technologies Anti-Counterfeiting and Product Protection Programme (A-CAPPP) Anti-Counterfeiting Group (ACG) Apoteket Applied DNA Sciences ARmark Authentication Technologies LLC AstraZeneca Australian Therapeutic Goods Administration (TGA) Authentix Automation Avery Dennison Axway Baxter Canadian Anti-Counterfeiting Network (CACN) Capsugel Cellular Bioengineering Inc. Center for Healthcare Supply Chain Research Center for Medicine in the Public Interest (US) CFC International www.visiongain.com
  16. 16. Contents Chesapeake Colorcon Cortegra Covectra Digital China Directorate General of Foreign Trade [India] Domino Drugs Standard Control Organisation DuPont European Alliance for Access to Safe Medicines (EAASM) European Commission European Directorate for the Quality of Medicines and Healthcare (EDQM), European Federation of Pharmaceutical Industries and Associations (EFPIA) European Medicines Agency Europol Everest Holovisions GlaxoSmithKline (GSK) Google Healthcare Distribution Management Association (HDMA) Heart UK Hologram Industries Holomex HOMAI (hologram manufactures association of India) Honeywell International Image Solutions Impinj Inc Ingenia Technology InkSure Technologies Intermec/ Interface Mechanisms International Anti-counterfeiting Association (IAA) www.visiongain.com
  17. 17. Contents International Anti-Counterfeiting Coalition (IACC) International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) International Ink Company International Medical Products Anti-Counterfeiting Taskforce (IMPACT) International Policy Network Interpol Japanese Pharmaceutical Manufacturers Association (JPMA) Johnson & Johnson Kodak Loughborough University LaserLock Massachusetts Institute of Technology (MIT) MasterCard Medicines and Healthcare products Regulatory Agency (MHRA) Medicrime Convention Council Menasha Corporation MicroTag Temed Ltd Microtrace Solutions Motorola NanoGuardian NanoInk Inc. Nanotech Security Corp. National Agency for Food and Drug Administration and Control (NAFDAC) [Nigeria] National Association of Boards of Pharmacy (NABP) National Health Surveillance Agency (ANVISA) Neri Labels Novartis Novavision OEP Technologie BV One Equity Partners OpSec Security www.visiongain.com
  18. 18. Contents Organisation for Economic Co-operation and Development (OECD) Pacific Holographics Paralec Inc Partner for Safe Medicines (PSM) India Pera Innovations Pfizer Pharmaceutical Research and Manufacturers of America (PhRMA) PharmaSecure Quality Brands Protection Committee (QBPC) [China] Reckitt Benckiser Roche Royal Pharmaceutical Society of Great Britain (RPSGB) Sanofi Savi Technology ScanSource Scientific Protein Laboratories (SPL) SICPA Siemens Smartrac South Dakota School of Mines and Technology State Food and Drug Administration (SFDA) [China] Sun Chemical Symbol Technologies Systech Tagsys RFID Teva Pharmaceuticals Texas Instruments The Caryle Group The International Hologram Manufacturers Association The Patients Association (UK) The Pharmaceutical Security Institute (PSI) www.visiongain.com
  19. 19. Contents ThermoFisher Scientific TruTag Technologies United Nations University of South Dakota UPM UPM Kymmene UPM Raflatac UPM Rafsec z US Center for Safe Internet Pharmacies (CSIP). US Food and Drugs Agency (FDA) US Pharmacopeial Convention (USP) Visa Vocollect Inc Voxtel Webscan World Customs Organization World Health Organization (WHO) World Intellectual Property Organization (WIPO) Zebra Technologies www.visiongain.com
  20. 20. Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2014-2024 Passive RFID tags operate without a separate external power source and obtain operating power generated from the reader. Passive tags are consequently much lighter than active tags, less expensive, and offer a virtually unlimited operational lifetime. The trade off is that they have shorter read ranges than active tags and require a higher-powered reader. Read-only tags are typically passive and are programmed with a unique set of data (usually 32 to 128 bits) that cannot be modified. Read-only tags most often operate as a licence plate into a database, in the same way as linear barcodes reference a database containing modifiable product-specific information. Figure 3.3 RFID Anti-counterfeiting Technologies: Drivers and Restraints, 2014-2024 Restraints Drivers • • Supply chain tracking capabilities, now promoted by many regulatory authorities High level of security against duplication • Tags can be read at distance • Wireless capabilities means identification is possible without the need to physically see the tag • RFID tags may contain personal information – potential for exposure of personal information • Generally a high cost technology • Requirement for specialized readers • Reliability, radio waves are deflected or impeded by certain materials interfering with signals Source: Visiongain 2013 The significant advantage of all types of RFID systems is the fact that authentication can be done remotely as the technology does not require contact between reader and tag (Figure 3.3). Tags can be read through a variety of substances such as snow, fog, ice, paint, dirt and other visually and environmentally challenging conditions, where barcodes or other optically read technologies would be useless. RFID tags can also be read in challenging circumstances at high speeds, in most cases responding in less than 100 milliseconds. The read/write capability of an active RFID system is also a significant advantage in interactive applications such as work-in-process or maintenance tracking. Although it is a costlier technology (compared with barcodes), RFID has become indispensable for a wide range of automated data collection and identification applications. Table 3.4 summarises the leading global manufacturers of RFID tags. www.visiongain.com Page 48
  21. 21. Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2014-2024 Table 4.16 Zebra Technologies: Product Groups and Descriptions, 2013 Technology Sector Description For UHF RFID and HF RFID in the supply chain and for other applications Passive RFID Encoded smart labels are printable labels embedded with an ultra-thin radio frequency transponder. Information encoded in these transponders can then be read and modified by a radio frequency reader. These labels eliminate the need of a visual ID of a barcode, as the ID signal is transmitted by radio frequency Falls under the branch of location solutions, software and hardware are used to locate, track, manage, and improve operational functions Active RFID Zebra’s location solutions include asset tags, call tags, sensors, exciters and application software. Active RFID products include, DartTag, WhereTag and WhereCall, incorporating various Real Time Locating System (RTLS) technologies based on ultra-wide band (UWB), WhereNet and Wi-Fi active RFID Thermal barcode technology Barcode printers with thermal-transfer and direct thermal technology produce accurate, high-quality images. Source: Zebra Technologies 2013, Visiongain 2013 The company operates within two branches – printing operations and location solutions. Within these branches the company’s product range consists of direct thermal and thermal transfer label and receipt printers, passive radio frequency identification (RFID) printer/encoders and dye sublimation card printers. They also sell specialty supplies consisting of self-adhesive labels, thermal transfer ribbons, thermal print-heads, batteries and other accessories, including software for label design and printer network management. Some of the technology branches and their applications are detailed in Table 4.16. It is difficult to estimate the company’s contribution to the pharmaceutical anti-counterfeiting sector because operations are spread over a range of industries. However, it is clear that Zebra Technologies is an industry leader in printing solutions to identify, authenticate, track-and-trace products. The company’s revenue in 2012 was $996.2m, which represents an increase of 1.3% from the previous year (Table 4.17 and Figure 4.8). www.visiongain.com Page 81
  22. 22. Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2014-2024 Table 5.9 Holograms/OVD: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024 2012 Hologram/OVD ($m) Annual Growth (%) CAGR (% 2012-2017 & 2017-2024) CAGR (% 2012-2024) 2013 2014 2015 80.7 85.5 6 90.6 6 97.9 105.7 113.1 121.0 127.1 133.4 140.1 148.5 155.9 162.2 8 8 7 7 5 5 5 6 5 4 2016 2017 2018 2019 2020 2021 2022 2023 7.0 2024 5.3 6.0 Source: Visiongain 2013 Figure 5.11 Holograms/OVD: Revenue Forecast ($m), 2012-2024 180 155.9 160 140.1 Revenue ($m) 140 127.1 100 80 133.4 113.1 120 97.9 85.5 162.2 148.5 121.0 105.7 90.6 80.7 60 40 20 0 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Year Source: Visiongain 2013 Holograms and optically variable devices fall into the category of overt technologies. Although they offer a relatively easy platform of anti-counterfeiting technology to implement – low cost and ease in which they can be applied, in recent years the risk of imitation has risen. Visiongain believes that potential security breaches and the strong growth of track-and-trace technologies (traditionally not holograms/OVD) will ultimately slow the growth of hologram/OVD market and reduce its market share. However, overall the hologram market will continue to see slow growth. Like most other sub-markets, growth in the pharmaceutical holograms market will be driven by pharmaceutical www.visiongain.com Page 99
  23. 23. Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2014-2024 8. Expert Opinions 8.1 Interview with Dr Fred Jordan, Chief Executive Officer, AlpVision In October 2013, visiongain interviewed Dr Fred Jordan (FJ), the chief executive officer of AlpVision. Topics discussed include AlpVision’s key technologies and the advancements in anticounterfeiting technologies, the increasing sophistication of counterfeiting criminals, and the main barriers and threats facing the implementation of anti-counterfeiting technologies. We thank Dr Jordan for his time and opinion. 8.1.1 Current State of Counterfeiting in the Pharmaceutical Industry Visiongain: How severe would you say the counterfeiting situation is within the pharmaceutical industry, and how do you see this changing in the next decade? FJ: Judging as a technology provider based on the number of requests we get from the pharmaceutical industry, if you take the top 50 pharmaceutical companies, I don’t know of any of these companies who have absolutely no anti-counterfeiting efforts; so all of them are doing something at some level. There are some exceptions for pharma companies who are only manufacturing generics. Looking at the interests of these companies gives an extent of the severity of the problem. Visiongain: Based on the information you have, where in the globe do you think the biggest counterfeiting threats lie? FJ: I don’t know where the biggest threat is, but what I know is from which companies we get the most requests. These are mainly European and US based companies. 8.1.2 AlpVison’s Key Technologies and Strategies for Combating Counterfeiters Visiongain: Could you give us an insight into AlpVision’s key technologies, especially those geared towards combating pharmaceutical anti-counterfeiting? FJ: Firstly, all the technologies that we have are dedicated to combating counterfeiting. We have two technologies: one is a printed technology which is appropriate for labels and packages. The other technology is for moulded plastic like caps, bottles, syringes and other moulded items. These are both used in the pharma field. www.visiongain.com Page 155

×